肝细胞肝癌合并微血管侵犯的诊疗进展

Therapeutic and diagnostic progress of hepatocellular carcinoma with microvascular invasion

微血管侵犯在肝癌中发生率较高,是肝癌治疗及预后评估的重要影响因素。本文综述了肝癌微血管侵犯相关的临床病理因素、术前预测肝癌合并微血管侵犯的研究进展,以及对术后病理证实的微血管侵犯的肝癌术后的干预,认为建立包含多因素的系统性预测肝癌合并微血管侵犯模型,将对肝癌合并微血管侵犯的治疗起到良好的指导作用并改善预后。

Currently, the incidence of complications after hepatectomy remains high, and perioperative management of hepatectomy is closely related to the occurrence of postoperative complications. Based on the evidence of evidence-based medical research and the experience of the latest clinical practice at multiple fiver surgery centers at home and abroad, some experts in the liver surgery group of the Chinese Medical Association Surgery Branch have repeatedly discussed and revised the ＂ Expert Consensus on Perioperative Management of Hepatectomy. ＂ The preoperative, postoperative and other aspects of the consensus was interpreted in this article.The incidence of microvascular invasion（MVI） in hepatocellular careinoma（HCC） is high, which is an important factor in the treatment and prognostic assessment of HCC. This paper summarizes the clinical and pathological factors related to hepatocellular carcinoma with microvascular invasion, advances in preoperative prediction of HCC with MVI, and the intervention of the postoperative pathologic confirmed HCC with MVI; and sugestes that the establishment of a multi-factr systematic predictive model ofhepatocellular carcinoma with microvascular invasion,will provide you sound guidance on the trealment of HCC with MVI, and improve the prognosis.